Article Text

other Versions

PDF
Concise report
A strong familiality of ankylosing spondylitis through several generations
  1. Arni Jon Geirsson1,
  2. Kristleifur Kristjansson2,
  3. Bjorn Gudbjornsson3,4
  1. 1Department of Rheumatology, University Hospital, Reyjavík, Iceland
  2. 2deCODE Genetics, Reykjavik, Iceland
  3. 3Centre for Rheumatology Research, University Hospital, Reyjavík, Iceland
  4. 4University of Iceland, Reykjavik, Iceland
  1. Correspondence to Bjorn Gudbjornsson, Centre for Rheumatology Research, Landspitali, Hringbraut – University Hospital, Reykjavik 101, Iceland; bjorngu{at}landspitali.is

Abstract

Objective To elucidate the familiality of ankylosing spondylitis (AS) in Iceland.

Methods The Icelandic genealogy database and population-wide data on all living Icelanders diagnosed as having AS (n=280), who previously had taken part in an epidemiological study on the prevalence of AS in Iceland, were included in the study. Identification of all interpatient relationships in the genealogy database allowed calculation of estimates of the RR for AS in the first-degree relatives (FDRs) to fourth-degree relatives of patients. For each AS proband, 1000 sets of matched Icelandic subjects in the genealogy database were used as controls.

Results FDRs, second-degree and third-degree relatives had RRs of 75.5, 20.2 and 3.5, respectively (all p values <0.0001), indicating a significantly increased risk for relatives of the patients with AS to develop AS, suggesting a strong heritable factor, while the fourth-degree relatives had a RR of 1.04 (p=0.476) for having AS.

Conclusions Patients with AS in Iceland are significantly more related to each other than to randomly sampled control subjects. This is in agreement with previous reports on the familiality of AS, but the present study has more power and extends over larger familiar cohorts than previously reported.

Statistics from Altmetric.com

Footnotes

  • Funding The study was funded by the research foundations of the University Hospital in Iceland, the Society for Rheumatology in Iceland and the Wyeth Rheumatology Foundation in Iceland.

  • Patient consent Obtained. All participants gave their written informed consent.

  • Ethics approval This study was conducted with the approval of the Icelandic Bioethics Committee and the Icelandic Data Protection Commission.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.